Orthofix Medical Earnings Review: Q4 Summary
Benzinga Insights 8 months ago
Earnings
The earnings results for Orthofix Medical (NASDAQ:OFIX) for Q4 were made public on Tuesday, February 24, 2026 at 07:00 AM.
Here's a comprehensive overview of the announcement.
Earnings
Orthofix Medical beat estimated earnings by 100.0%, reporting an EPS of $0.24 versus an estimate of $0.12.
Revenue was up $4.25 million from the same period last year.
Performance in Previous Earnings
The company beat on EPS by $0.38 in the last quarter, resulting in a 0.67% increase share price change the following day.
Here's a look at Orthofix Medical's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.15 | -0.270 | -0.05 |
| EPS Actual | 0.20 | 0.13 | -0.081 | 0.02 |
| Revenue Estimate | 200.14M | 196.76M | 191.10M | 212.72M |
| Revenue Actual | 205.60M | 203.12M | 193.65M | 215.66M |
To track all earnings releases for Orthofix Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.